124 related articles for article (PubMed ID: 180741)
1. Plasma aldosterone concentrations related to 17alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
Pham-Huu-Trung MT; Raux MC; Gourmelen M; Baron MC; Girard F
Acta Endocrinol (Copenh); 1976 Jul; 82(3):572-86. PubMed ID: 180741
[TBL] [Abstract][Full Text] [Related]
2. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[TBL] [Abstract][Full Text] [Related]
3. Congenital adrenal hyperplasia: renin and steroid values during treatment.
Grant DB; Dillon MJ; Atherden SM; Levinsky RJ
Eur J Pediatr; 1977 Aug; 126(1-2):86-96. PubMed ID: 902665
[TBL] [Abstract][Full Text] [Related]
4. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
Parth K; Zimprich H; Swoboda W; Brunel R; Bohrn E
Acta Endocrinol (Copenh); 1978 Jan; 87(1):148-57. PubMed ID: 202131
[No Abstract] [Full Text] [Related]
5. ALDOSTERONE- AND CORTISOL SECRETION RATES IN INFANTS AND CHILDREN WITH CONGENITAL ADRENAL HYPERPLASIA SUGGESTING DIFFERENT 21-HYDROXYLATION DEFECTS IN "SALT-LOSERS" AND "NON SALT-LOSERS".
DEGENHART HJ; VISSER HK; WILMINK R; CROUGHS W
Acta Endocrinol (Copenh); 1965 Apr; 48():587-601. PubMed ID: 14288879
[No Abstract] [Full Text] [Related]
6. Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
Limal JM; Rappaport R; Bayard F
J Clin Endocrinol Metab; 1977 Sep; 45(3):551-9. PubMed ID: 198427
[No Abstract] [Full Text] [Related]
7. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P
J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of plasma renin activity and plasma aldosterone level during dexamethasone suppression test in non-salt-losers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kinoshita K; Ishida H; Minowada S; Niijima T
Endocrinol Jpn; 1980 Dec; 27(6):747-51. PubMed ID: 7021135
[TBL] [Abstract][Full Text] [Related]
9. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
Beitins IZ; Bayard F; Kowarski A; Migeon CJ
J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790
[No Abstract] [Full Text] [Related]
10. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
11. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Shibata Y
Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324
[TBL] [Abstract][Full Text] [Related]
12. 17-Hydroxyprogesterone in normal children and congenital adrenal hyperplasia. Measurement in serum by radioimmunoassay after thin-layer chromatography.
Petersen KE; Christensen T
Acta Paediatr Scand; 1979 Mar; 68(2):205-11. PubMed ID: 217232
[TBL] [Abstract][Full Text] [Related]
13. 17-Hydroxyprogesterone in the cosyntropin test: results in normal and hirsute women and in mild congenital adrenal hyperplasia.
Gourmelen M; Pham-Huu-Trung MT; Bredon MG; Girard F
Acta Endocrinol (Copenh); 1979 Mar; 90(3):481-9. PubMed ID: 218414
[TBL] [Abstract][Full Text] [Related]
14. Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia.
Strott CA; Yoshimi T; Lipsett MB
J Clin Invest; 1969 May; 48(5):930-9. PubMed ID: 4305376
[TBL] [Abstract][Full Text] [Related]
15. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations.
Golden MP; Lippe BM; Kaplan SA; Lavin N; Slavin J
Pediatrics; 1978 Jun; 61(6):867-71. PubMed ID: 149950
[TBL] [Abstract][Full Text] [Related]
16. Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone.
Youssefnejadian E; David R
Clin Endocrinol (Oxf); 1975 Jul; 4(4):451-54. PubMed ID: 168994
[TBL] [Abstract][Full Text] [Related]
17. Salt-losers and non salt-losers in congenital adrenal hyperplasia.
Bartter FC
Arch Dis Child; 1969 Feb; 44(233):138-9. PubMed ID: 4303934
[No Abstract] [Full Text] [Related]
18. [Renin-angiotensin and hypophyseo-adrenal systems in children suffering from congenital adrenocortical hyperplasia resulting from 21-hydroxylase deficiency].
Kasatkina EP; Tiul'pakov AN; Ibragimova GV; Litvinova NN
Probl Endokrinol (Mosk); 1991; 37(6):p66. PubMed ID: 1664952
[TBL] [Abstract][Full Text] [Related]
19. Suppression and stimulation of mineralocorticoid hormones (MCH) in the simple virilizing form of congenital adrenal hyperplasia (CAH) evaluated by the quantitation in adrenal venous blood.
Wajchenberg BL; Biglieri EG; Okada H; Malerbi DA; Achando SS; Kater CE
J Steroid Biochem; 1983 Jul; 19(1B):655-61. PubMed ID: 6350722
[TBL] [Abstract][Full Text] [Related]
20. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia.
Horner JM; Hintz RL; Luetscher JA
J Clin Endocrinol Metab; 1979 May; 48(5):776-83. PubMed ID: 219009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
